🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, open-label, single-arm study to investigate the safe...
Status
Completed
Location
The Angeles Clinic and Research Institute
Start Date
2023-01-05
Trial ID
NCT05577182
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of recombi...
Status
Not Yet Recruiting
Location
Air Force Military Medical University/ Fourth Military Medical University
Start Date
2022-09-30
Trial ID
NCT05539118
Treatments Being Tested
This study is designed to evaluate the safety and efficacy of QLF31907 comb...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-06-15
Trial ID
NCT06394713
Treatments Being Tested
This is a randomized, open-label study of Serplulimab plus chemotherapy (Ca...
Status
Active Not Recruiting
Location
Alabama Oncology
Start Date
2022-11-18
Trial ID
NCT05468489
This study is to evaluate a novel cytotoxic anti-PD-L1, IUAb190708, for the...
Status
Recruiting
Location
Fujian Cancer Hospital
Start Date
2024-06-18
Trial ID
NCT07584954
Treatments Being Tested
The combination of an anti-PD-1/PD-L1 antibody with an angiogenesis inhibit...
Status
Unknown
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2022-05-05
Trial ID
NCT05349045
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12
Trial ID
NCT03167177
This prospective observational study aims to evaluate whether immune profil...
Status
Not Yet Recruiting
Location
SMG-SNU Boramae Medical Center
Start Date
2026-01
Trial ID
NCT07331701
The main goals are after treatment given before surgery, to measure the num...
Status
Recruiting
Location
Southern Cancer Center (SCC) ( Site 8004)
Start Date
2025-03-20
Trial ID
NCT06788912
This global, multicenter, open-label study will evaluate the safety and tol...
Status
Completed
Location
HonorHealth Research Institute - Bisgrove
Start Date
2014-08-18
Trial ID
NCT02174172
Treatments Being Tested